Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $141,750 | 2 | 97.5% |
| Travel and Lodging | $2,627 | 8 | 1.8% |
| Food and Beverage | $959.58 | 10 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $142,685 | 11 | $0 (2017) |
| HOSPIRA, INC. | $2,250 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $208.03 | 2 | $0 (2019) |
| AbbVie, Inc. | $100.00 | 1 | $0 (2017) |
| Celgene Corporation | $64.95 | 4 | $0 (2018) |
| Abbott Laboratories | $28.85 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $28.85 | 1 | Abbott Laboratories ($28.85) |
| 2019 | $109.64 | 1 | Novartis Pharmaceuticals Corporation ($109.64) |
| 2018 | $13.80 | 1 | Celgene Corporation ($13.80) |
| 2017 | $145,185 | 17 | PFIZER INC. ($142,685) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/27/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: Neuromodulation | ||||||
| 11/09/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $109.64 | General |
| Category: IMMUNOLOGY | ||||||
| 02/15/2018 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $13.80 | General |
| 12/08/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $18.36 | General |
| 08/24/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $11.13 | General |
| 08/14/2017 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $139,500.00 | General |
| 08/05/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $21.66 | General |
| 07/19/2017 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $98.39 | General |
| Category: DERMATOLOGY | ||||||
| 06/07/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $146.00 | General |
| 05/25/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $777.40 | General |
| 05/25/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $534.18 | General |
| 05/25/2017 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $407.65 | General |
| 05/25/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $129.06 | General |
| 05/15/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| 05/02/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $100.00 | General |
| 04/20/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $47.70 | General |
| 04/07/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $525.54 | General |
| 04/07/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $286.29 | General |
| 04/07/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $181.26 | General |
| 04/07/2017 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $150.10 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 86 | 779 | $55,458 | $16,658 |
| 2022 | 3 | 47 | 62 | $9,340 | $3,297 |
| 2021 | 3 | 48 | 72 | $11,795 | $3,875 |
| 2020 | 3 | 57 | 65 | $8,385 | $3,779 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 11 | 660 | $36,540 | $11,978 | 32.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 21 | 40 | $9,000 | $1,778 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 28 | $4,228 | $1,688 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 13 | $3,068 | $908.84 | 29.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 38 | $2,622 | $305.49 | 11.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 20 | $4,720 | $1,852 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 21 | $3,171 | $1,227 | 38.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 21 | $1,449 | $217.90 | 15.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 25 | $5,900 | $2,571 | 43.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 11 | 17 | $3,825 | $983.81 | 25.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 30 | $2,070 | $319.76 | 15.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 29 | 33 | $2,629 | $1,716 | 65.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 14 | $1,652 | $1,124 | 68.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 18 | $4,104 | $938.84 | 22.9% |
About Dr. Benjamin Schwartz, MD
Dr. Benjamin Schwartz, MD is a Rheumatology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275550782.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Schwartz, MD has received a total of $145,337 in payments from pharmaceutical and medical device companies, with $28.85 received in 2023. These payments were reported across 20 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($141,750).
As a Medicare-enrolled provider, Schwartz has provided services to 238 Medicare beneficiaries, totaling 978 services with total Medicare billing of $27,608. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Saint Louis, MO
- Active Since 07/17/2006
- Last Updated 04/17/2025
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1275550782
Products in Payments
- COSENTYX (Biological) $208.03
- PROCLAIM (Device) $28.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Saint Louis
Dr. Alfred Kim, Md, MD
Rheumatology — Payments: $402,454
Dr. Sona Kamat, M.d, M.D
Rheumatology — Payments: $266,392
Dr. Adam Kilian, M.d, M.D
Rheumatology — Payments: $259,162
Akgun Ince, M.d, M.D
Rheumatology — Payments: $55,223
Dr. Sandra Hoffmann, M.d, M.D
Rheumatology — Payments: $29,229
Dr. John Budd, Md, MD
Rheumatology — Payments: $27,292